Document is current
Any future updates will be listed below
-
Authors
Drugeon, Bertrand https://orcid.org/0000-0003-1026-7975
Rickard, Claire M. https://orcid.org/0000-0002-6341-7415
Buetti, Niccolò https://orcid.org/0000-0002-8096-1834
Guenezan, Jérémy https://orcid.org/0000-0002-4736-1490
Mimoz, Olivier https://orcid.org/0000-0003-1737-7915
-
Funding
Funding for this research was provided by:
The University of Queensland
- License Information
-
More Information
Article History
Accepted: 18 June 2025
First Online: 27 June 2025
Declarations
:
: OM, BD and JG received funding for congress attendance, and research funding from Becton Dickinson and 3M/Solventum.CMR’s employer (University of Queensland or Griffith University) received unrestricted investigator-initiated research on my behalf from BD, 3M/Solventum, and Cardinal Health, educational grants for the AVATAR group from 3M/Solventum, Angiodynamics, Spectrum Vascular, and ICU Medical, and consultancy payments for lectures or expert opinion from 3M, BBraun, and ITL Biomedical.NB received funding from the Swiss National Science Foundation.
